This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuromitsu, J. Articles by Hayashizaki, Y. Search for Related Content PubMed PubMed Citation Articles by Kuromitsu, J. Articles by Hayashizaki, Y.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 02 1997, 707-712, Vol 17, No. 2
Copyright © 1997, American Society for Microbiology

A unique downregulation of h2-calponin gene expression in Down syndrome: a possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21

J Kuromitsu, H Yamashita, H Kataoka, T Takahara, M Muramatsu, T Sekine, N Okamoto, Y Furuichi and Y Hayashizaki
Genome Science Laboratory, RIKEN Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Tsukuba, Ibaraki, Japan.

To understand the effect of trisomic chromosome 21 on the cause of Down syndrome (DS), DNA methylation in the CpG island, which regulates the expression of adjacent genes, was investigated with the DNAs of chromosome 21 isolated from DS patients and their parents. A methylation-sensitive enzyme, BssHII, was used to digest DNAs of chromosome 21, and the resulting DNA fragments were subjected to RLGS (restriction landmark genomic scanning). Surprisingly, the CpG island of the h2-calponin gene was shown to be specifically methylated by comparative studies with RLGS and Southern blot analysis. In association with this methylation, h2-calponin gene expression was attenuated to the normal level, although other genes in the DS region of chromosome 21 were expressed dose dependently at 1.5 times the normal level. These results and the high miscarriage rate associated with trisomy 21 embryos imply that the altered in vivo methylation that attenuates downstream gene expression, which is otherwise lethal, permits the generation of DS neonates. The h2-calponin gene detected by the RLGS procedure may be one such gene that is attenuated.

This article has been cited by other articles:

• Yamada, Y., Watanabe, H., Miura, F., Soejima, H., Uchiyama, M., Iwasaka, T., Mukai, T., Sakaki, Y., Ito, T. (2004). A Comprehensive Analysis of Allelic Methylation Status of CpG Islands on Human Chromosome 21q. Genome Res 14: 247-266 [Abstract] [Full Text]  
• Ge, Y., Jensen, T. L., Matherly, L. H., Taub, J. W. (2003). Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines. Blood 101: 1551-1557 [Abstract] [Full Text]  
• Poon, L. L.M., Leung, T. N., Lau, T. K., Chow, K. C.K., Lo, Y.M. D. (2002). Differential DNA Methylation between Fetus and Mother as a Strategy for Detecting Fetal DNA in Maternal Plasma. Clin. Chem. 48: 35-41 [Abstract] [Full Text]